Residual DNA Testing Market: Growth, Size, Share, and Trends
Residual DNA Testing Market by Product & Service (Consumable, Instrument & Software), Technology (PCR), Test Type (Raw, Final, Bulk Lot Release Testing), Application (mAb, CGT, Vaccine), End User (Pharma & Biotech, CRO & CDMO) - Global Forecast to 2030
USD 0.37 BN
MARKET SIZE, 2030
CAGR 6%
(2025-2030)
350
REPORT PAGES
450
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The residual DNA testing market is projected to reach USD 0.37 billion by 2030 from USD 0.28 billion in 2025 at a CAGR of 6.0% from 2025 to 2030. The market growth is fueled by increasing number of biologics & biosimilar approvals and stringent regulatory compliance requirements.
KEY TAKEAWAYS
- The North America residual DNA testing market accounted for a 40.0% revenue share in 2024.
- By offering, the services segment is expected to register the highest CAGR of 6.9%.
- By test type, the final product release testing segment is projected to grow at the fastest rate from 2025 to 2030.
- By technology, the polymerase chain reaction (PCR) segment is expected to dominate the market.
- By application, the cell & gene therapy segment will grow the fastest during the forecast period.
- By end user, the pharmaceutical & biotechnology companies held the largest share of 70.9% of the residual DNA testing products market in 2024.
- By end user, the pharmaceutical & biotechnology companies segment is expected to grow at the fastest rate during the forecast period.
- Thermo Fisher Scientific Inc., Merck KGaA, and Maravai LifeSciences were identified as some of the star players in the residual DNA testing market (global), given their strong market share and product/service footprint.
- Companies like Minerva Biolabs GmbH, TransGen Biotech Co., Ltd., Creative Biogene, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders
The residual DNA testing market is projected to grow rapidly over the next decade, supported by high growth opportunities in emerging countries. The growth is mainly driven by the increasing number of biologics & biosimilar approvals, as well as stringent regulatory compliance requirements. Additionally, technological advancements in DNA quantification and detection further propel growth in this market.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The residual DNA testing market is undergoing a structural transformation driven by technological advancements, regulatory harmonization, and the expansion of its application scope across biologics and cell and gene therapy workflows. Future revenue growth is expected to be shaped by new use cases, automation, and integration with bioprocess analytics. Pharmaceutical and biotechnology companies are emphasizing regulatory-compliant quantification and assay validation, while CROs and CDMOs focus on GMP-ready automation and audit readiness. Academic and research institutes are advancing vector detection and data standardization, thereby fostering reproducibility, accelerating translation, and providing deeper insights into biological processes.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Increasing number of biologics and biosimilar approvals
-
Stringent regulatory compliance requirements
RESTRAINTS
Impact
Level
Level
-
High costs of advanced testing techniques
-
Lack of standardization across testing protocols
OPPORTUNITIES
Impact
Level
Level
-
Rising number of applications in novel modalities
-
High growth opportunities in emerging markets
CHALLENGES
Impact
Level
Level
-
Complexity in sample preparation and assay validation
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing number of biologics and biosimilar approvals
The surge in approvals of biologics and biosimilars globally is driving the demand for residual DNA testing. As regulatory authorities mandate stringent safety and quality assessments, manufacturers are increasingly adopting DNA testing solutions to ensure product purity and compliance, fueling market growth across pharmaceutical, biotechnology, and contract testing sectors.
Restraint: High costs of advanced testing techniques
Their high costs constrain the adoption of advanced residual DNA testing techniques. Sophisticated instruments, reagents, and skilled personnel requirements create significant financial barriers for small and medium-sized enterprises, limiting widespread implementation and slowing market penetration despite growing regulatory pressures.
Opportunity: Rising number of applications in novel modalities
The market presents significant opportunities through the expanding use of residual DNA testing in emerging therapeutic modalities, including cell and gene therapies, RNA-based therapeutics, and personalized medicine. As these novel modalities grow, the demand for reliable DNA testing services and products to ensure product safety and quality is expected to accelerate.
Challenge: Complexity in sample preparation and assay validation
Residual DNA testing faces challenges due to the complexity of sample preparation procedures and rigorous assay validation requirements. Ensuring accuracy, reproducibility, and compliance with regulatory standards requires specialized expertise and time-intensive processes, posing operational hurdles for laboratories and service providers that impact throughput and scalability.
Residual DNA Testing Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Employed residual DNA testing in plasmid DNA manufacturing for gene therapies | Used quantitative PCR and process development to ensure minimal host cell DNA contamination in plasmid batches for clinical and commercial uses | Ensured regulatory compliance, improved plasmid purity and safety, increased client confidence, and supported scalable gene therapy manufacturing |
 |
Tested 28 batches of mRNA vaccines for residual host cell DNA using qPCR methods to quantify DNA fragments in final vaccine products | Wide assay portfolio; global lab network; scalable testing capacity for large biopharma clients |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The residual DNA testing market ecosystem consists of raw material suppliers (New England Biolabs, Merck KGaA), product manufacturers (Thermo Fisher Scientific Inc., QIAGEN), service providers (Charles River Laboratories, Bio-Rad Laboratories, Inc.), regulatory bodies (US Food and Drug Administration, European Medicines Agency), and end users (Pfizer Inc., AstraZeneca). Raw materials, including reagents, enzymes, kits, and consumables, are utilized by laboratories and service providers to perform high-precision residual DNA testing on biologics, vaccines, and novel therapeutics. End users drive demand for accuracy, sensitivity, and regulatory compliance, while providers ensure the validation of assays, reliable instrumentation, and scalable testing workflows. Collaboration across the value chain is essential to innovation, streamlined testing processes, and overall market growth.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Residual DNA Testing Market, By Offering
In 2024, the products segment dominated the residual DNA testing market, driven by the rapid expansion of the global biopharmaceutical industry. Additionally, advancements in molecular diagnostics, such as digital PCR and qPCR, are enhancing the precision and throughput of residual DNA testing.
Residual DNA Testing Market, By Test Type
In 2024, the final product release segment dominated the residual DNA testing market, attributed to the rising commercialization of biologics and the need to ensure patient safety.
Residual DNA Testing Market, By Application
In 2024, the monoclonal antibodies segment accounted for the largest share of the residual DNA testing market. The industry-standard use of Chinese Hamster Ovary (CHO) cells presents a consistent source of host cell DNA risk, which is expected to boost the demand for the monoclonal antibodies segment.
REGION
Asia Pacific to be fastest-growing region in global residual DNA testing market during forecast period
The Asia Pacific residual DNA testing market is expected to register the highest CAGR during the forecast period, primarily due to favorable government initiatives and funding and increasing R&D spending by pharmaceutical & biotechnology companies to advance the healthcare sector.
Residual DNA Testing Market: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific Inc. (Star) leads the residual DNA testing market with a strong market share and a comprehensive product and service portfolio, driven by its high-quality reagents, instruments, and validated testing solutions widely adopted across biologics, vaccines, and novel therapeutic development. FUJIFILM Corporation (Emerging Leader) is gaining traction with its innovative testing platforms, assay kits, and tailored service offerings, strengthening its position through niche solutions and technological advancements. While Thermo Fisher dominates through scale, regulatory compliance expertise, and a broad portfolio, FUJIFILM shows significant potential to move toward the leaders’ quadrant as demand for precise, scalable, and reliable residual DNA testing continues to grow.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc. (US)
- Charles River Laboratories (US)
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Merck KGaA (Germany)
- Maravai LifeSciences (US)
- Eurofins Scientific (Luxembourg)
- Bio-Rad Laboratories, Inc. (US)
- QIAGEN (Germany)
- FUJIFILM Corporation (Japan)
- SGS Societé Génerale de Surveillance SA. (Switzerland)
- Jiagnsu Hillgene Biopharma Co., Ltd. (China)
- Revvity (US)
- Intertek Group plc (UK)
- Sartorius AG (Germany)
- Lonza (Switzerland)
- WuXi AppTec (China)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 0.27 Billion |
| Market Forecast in 2030 (value) | USD 0.37 Billion |
| Growth Rate | CAGR of 6.0% from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: Residual DNA Testing Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Rest of Europe breakdown |
|
Provides granular country-level insights, enabling clients to prioritize high-growth markets and tailor portfolio strategies across products and services for maximum regional impact |
| Company Evaluation |
|
Delivers visibility into competitors, helping clients identify partners, evaluate positioning, and detect market gaps for smarter collaboration, outsourcing, and strategic market entry decisions |
RECENT DEVELOPMENTS
- April 2025 : Thermo Fisher Scientific announced plans to invest USD 2 billion in the US over the next four years to strengthen its innovation, manufacturing, and economic competitiveness across the life sciences sector.
- February 2025 : Bio-Rad acquired Stilla Technologies to strengthen its digital PCR portfolio, with applications in cell and gene therapy, residual DNA testing, and infectious disease detection.
- September 2024 : Eurofins Scientific acquired Infinity Laboratories to expand its BioPharma product testing offering in the US.
- September 2024 : Qiagen launched 100 new assays for its digital PCR (dPCR) platform, QIAcuity, to enable accurate and sensitive detection of low-abundance pathogens, copy number alterations, and identification of rare mutations.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
36
2
RESEARCH METHODOLOGY
40
3
EXECUTIVE SUMMARY
52
4
PREMIUM INSIGHTS
57
5
MARKET OVERVIEW
Biologics boom and tech advances drive DNA testing market, despite regulatory and cost challenges.
60
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
INCREASING NUMBER OF BIOLOGICS AND BIOSIMILAR APPROVALS
5.2.1.2
STRINGENT REGULATORY COMPLIANCE REQUIREMENTS
5.2.1.3
TECHNOLOGICAL ADVANCEMENTS IN DNA QUANTIFICATION AND DETECTION
5.2.1.4
INCREASING RISK OF CELL CULTURE CONTAMINATION
5.2.1.5
RISING BIOPHARMACEUTICAL R&D INVESTMENTS
5.2.2
RESTRAINTS
5.2.2.1
HIGH COSTS OF ADVANCED TESTING TECHNIQUES
5.2.2.2
LACK OF STANDARDIZATION ACROSS TESTING PROTOCOLS
5.2.3
OPPORTUNITIES
5.2.3.1
RISING NUMBER OF APPLICATIONS IN NOVEL MODALITIES
5.2.3.2
HIGH GROWTH OPPORTUNITIES IN EMERGING MARKETS
5.2.3.3
INTEGRATION WITH CONTINUOUS AND ACCELERATED BIOPROCESSING
5.2.3.4
RISING OUTSOURCING TO CROS AND CDMOS
5.2.4
CHALLENGES
5.2.4.1
COMPLEXITY IN SAMPLE PREPARATION AND ASSAY VALIDATION
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4
PRICING ANALYSIS
5.4.1
AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY KEY PLAYER, 2022–2024
5.4.2
AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY REGION, 2022–2024
5.5
VALUE CHAIN ANALYSIS
5.6
ECOSYSTEM ANALYSIS
5.6.1
ROLE IN ECOSYSTEM
5.7
INVESTMENT & FUNDING SCENARIO
5.8
TECHNOLOGY ANALYSIS
5.8.1
KEY TECHNOLOGIES
5.8.1.1
QUANTITATIVE PCR (QPCR)
5.8.1.2
DROPLET DIGITAL PCR (DDPCR)
5.8.1.3
NEXT-GENERATION SEQUENCING (NGS)
5.8.2
COMPLEMENTARY TECHNOLOGIES
5.8.2.1
AUTOMATED MAGNETIC BEAD-BASED DNA EXTRACTION
5.8.2.2
CAPILLARY ELECTROPHORESIS
5.8.2.3
NANOPORE SEQUENCING
5.8.3
ADJACENT TECHNOLOGIES
5.8.3.1
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
5.8.3.2
ELECTRON MICROSCOPY
5.8.3.3
MASS SPECTROMETRY
5.9
PATENT ANALYSIS
5.9.1
LIST OF KEY PATENTS
5.10
KEY CONFERENCES & EVENTS, 2025–2026
5.11
REGULATORY ANALYSIS
5.11.1
REGULATORY FRAMEWORK
5.11.1.1
NORTH AMERICA
5.11.1.2
EUROPE
5.11.1.3
ASIA PACIFIC
5.11.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12
PORTER’S FIVE FORCES ANALYSIS
5.12.1
BARGAINING POWER OF SUPPLIERS
5.12.2
BARGAINING POWER OF BUYERS
5.12.3
THREAT OF NEW ENTRANTS
5.12.4
THREAT OF SUBSTITUTES
5.12.5
INTENSITY OF COMPETITIVE RIVALRY
5.13
KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2
KEY BUYING CRITERIA, BY END USER
5.14
IMPACT OF AI/GEN AI ON RESIDUAL DNA TESTING MARKET
5.14.1
MARKET POTENTIAL OF AI IN RESIDUAL DNA TESTING
5.14.2
AI USE CASES
5.14.3
KEY COMPANIES IMPLEMENTING AI/GEN AI
5.14.4
FUTURE OF AI/GEN AI IN RESIDUAL DNA TESTING MARKET
5.15
TRADE DATA ANALYSIS
5.15.1
IMPORT DATA FOR HS CODE 9027, 2020–2024
5.15.2
EXPORT DATA FOR HS CODE 9027, 2020–2024
5.16
IMPACT OF 2025 US TARIFF ON RESIDUAL DNA TESTING MARKET
5.16.1
KEY TARIFF RATES
5.16.2
PRICE IMPACT ANALYSIS
5.16.3
IMPACT ON COUNTRIES/REGIONS
5.16.3.1
NORTH AMERICA
5.16.3.2
EUROPE
5.16.3.3
ASIA PACIFIC
5.16.3.4
REST OF THE WORLD
5.16.4
IMPACT ON END-USE INDUSTRIES
5.16.4.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.16.4.2
CROS & CDMOS
5.16.4.3
ACADEMIC & RESEARCH INSTITUTES
6
RESIDUAL DNA TESTING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 30 Data Tables
100
6.1
INTRODUCTION
6.2
PRODUCTS
6.2.1
CONSUMABLES
6.2.1.1
INCREASING FOCUS ON DEVELOPMENT OF BIOLOGICS AND BIOSIMILARS TO PROPEL SEGMENT GROWTH
6.2.2
INSTRUMENTS & SOFTWARE
6.2.2.1
CONTINUOUS ADVANCEMENT IN ANALYTICAL TECHNOLOGIES TO FUEL SEGMENT GROWTH
6.3
SERVICES
6.3.1
STRINGENT REGULATORY STANDARDS TO PROMOTE MARKET GROWTH
7
RESIDUAL DNA TESTING MARKET, BY TEST TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
116
7.1
INTRODUCTION
7.2
FINAL PRODUCT RELEASE TESTING
7.2.1
FAVORABLE REGULATORY MANDATES AND BIOLOGICS INNOVATION TO FUEL MARKET GROWTH
7.3
BULK LOT RELEASE TESTING
7.3.1
INCREASING BIOLOGIC COMPLEXITY TO FUEL MARKET GROWTH
7.4
RAW MATERIAL TESTING
7.4.1
ENHANCED FOCUS ON PRODUCT SAFETY AND REGULATORY COMPLIANCE TO AUGMENT MARKET GROWTH
8
RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
128
8.1
INTRODUCTION
8.2
POLYMERASE CHAIN REACTION
8.2.1
HIGH THROUGHPUT DETECTION TO SUPPORT SEGMENT DOMINANCE
8.3
THRESHOLD ASSAYS
8.3.1
HIGH SPECIFICITY OF DNA DETECTION AT LOW CONCENTRATION TO FUEL MARKET GROWTH
8.4
DNA PROBE HYBRIDIZATION
8.4.1
EASY-TO-USE PORTFOLIO TO BOOST ADOPTION OF DNA PROBE HYBRIDIZATION
8.5
OTHER TECHNOLOGIES
9
RESIDUAL DNA TESTING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 29 Data Tables
144
9.1
INTRODUCTION
9.2
MONOCLONAL ANTIBODIES
9.2.1
EXPANSION OF BIOSIMILAR PIPELINE TO AID MARKET GROWTH
9.3
CELL & GENE THERAPY
9.3.1
RISING POPULARITY OF VIRAL VECTOR-BASED SYSTEMS AND INCREASING REGULATORY APPROVALS TO AID MARKET GROWTH
9.4
VACCINES
9.4.1
PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
9.5
OTHER APPLICATIONS
10
RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
159
10.1
INTRODUCTION
10.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1
HIGH BIOPHARMACEUTICAL R&D SPENDING AND INCREASED REGULATORY PRESSURE TO FUEL MARKET GROWTH
10.3
CROS & CDMOS
10.3.1
FOCUS ON BIOLOGICS DEVELOPMENT AND CDMO FACILITY EXPANSION TO BOOST MARKET GROWTH
10.4
ACADEMIC & RESEARCH INSTITUTES
10.4.1
SURGE IN R&D ACTIVITIES FOR DEVELOPMENT OF ADVANCED THERAPIES TO DRIVE MARKET GROWTH
11
RESIDUAL DNA TESTING SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 15 Data Tables
171
11.1
INTRODUCTION
11.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.2.1
SURGE IN R&D INVESTMENTS IN BIOPHARMACEUTICAL INNOVATION TO PROPEL MARKET GROWTH
11.3
ACADEMIC & RESEARCH INSTITUTES
11.3.1
SSLIMITED IN-HOUSE CAPABILITIES TO DRIVE OUTSOURCING
12
RESIDUAL DNA TESTING MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 217 Data Tables.
180
12.1
INTRODUCTION
12.2
NORTH AMERICA
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2
US
12.2.2.1
US TO DOMINATE NORTH AMERICAN RESIDUAL DNA TESTING MARKET DURING STUDY PERIOD
12.2.3
CANADA
12.2.3.1
INCREASING GOVERNMENT SUPPORT FOR BIOLOGICS MANUFACTURING AND RISING RESEARCH FUNDING TO PROPEL MARKET GROWTH
12.3
EUROPE
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2
GERMANY
12.3.2.1
INCREASING INVESTMENTS IN BIOPHARMA AND RISING FOCUS ON DEVELOPING MANUFACTURING CAPABILITIES TO DRIVE MARKET
12.3.3
UK
12.3.3.1
BOOMING LIFE SCIENCE INDUSTRY AND GROWING FOCUS ON VACCINE DEVELOPMENT TO AID MARKET GROWTH
12.3.4
FRANCE
12.3.4.1
GROWING BIOTECHNOLOGY SECTOR AND RISING RESEARCH FUNDING TO DRIVE MARKET
12.3.5
ITALY
12.3.5.1
HIGH R&D INVESTMENTS IN LIFE SCIENCES RESEARCH TO AUGMENT MARKET GROWTH
12.3.6
SPAIN
12.3.6.1
INCREASING NUMBER OF BIOTECH COMPANIES TO FAVOR MARKET GROWTH
12.3.7
REST OF EUROPE
12.4
ASIA PACIFIC
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2
CHINA
12.4.2.1
HIGH R&D EXPENDITURE AND FAVORABLE STRATEGIC ALLIANCES TO PROPEL MARKET GROWTH
12.4.3
JAPAN
12.4.3.1
FAVORABLE GOVERNMENT INITIATIVES FOR DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
12.4.4
INDIA
12.4.4.1
INCREASING R&D INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
12.4.5
SOUTH KOREA
12.4.5.1
INCREASING STRATEGIC ALLIANCES AND INVESTMENTS TO SPUR MARKET GROWTH
12.4.6
AUSTRALIA
12.4.6.1
BOOMING LIFE SCIENCE SECTOR TO FUEL MARKET GROWTH
12.4.7
REST OF ASIA PACIFIC
12.5
LATIN AMERICA
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2
BRAZIL
12.5.2.1
SUBSTANTIAL R&D INVESTMENTS BY PHARMACEUTICAL COMPANIES TO FUEL MARKET GROWTH
12.5.3
MEXICO
12.5.3.1
RISING GOVERNMENT SUPPORT FOR BIOPHARMACEUTICAL PRODUCTION TO DRIVE MARKET
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
12.6.2
GCC COUNTRIES
12.6.2.1
KINGDOM OF SAUDI ARABIA
12.6.2.2
UAE
12.6.2.3
REST OF GCC COUNTRIES
12.6.3
REST OF MIDDLE EAST
12.7
AFRICA
12.7.1
RISING PREVALENCE OF CHRONIC DISEASES AND INCREASING FUNDING FOR BIOPHARMA SECTOR TO FUEL MARKET GROWTH
12.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
13
COMPETITIVE LANDSCAPE
Discover key player strategies shaping the residual DNA testing market's competitive dynamics.
273
13.1
INTRODUCTION
13.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RESIDUAL DNA TESTING MARKET
13.3
REVENUE ANALYSIS, 2020–2024
13.4
MARKET SHARE ANALYSIS, 2024
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.5.1
STARS
13.5.2
EMERGING LEADERS
13.5.3
PERVASIVE PLAYERS
13.5.4
PARTICIPANTS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
OFFERING FOOTPRINT
13.5.5.4
TECHNOLOGY FOOTPRINT
13.5.5.5
TEST TYPE FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.3
DYNAMIC COMPANIES
13.6.4
STARTING BLOCKS
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7
COMPANY VALUATION & FINANCIAL METRICS
13.7.1
FINANCIAL METRICS
13.7.2
COMPANY VALUATION
13.8
BRAND/PRODUCT COMPARISON
13.9
COMPETITIVE SCENARIO
13.9.1
PRODUCT LAUNCHES
13.9.2
DEALS
13.9.3
OTHER DEVELOPMENTS
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
293
14.1
KEY PLAYERS
14.1.1
THERMO FISHER SCIENTIFIC INC.
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS/SERVICES OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.4
MNM VIEW
14.1.2
CHARLES RIVER LABORATORIES
14.1.3
F. HOFFMANN-LA ROCHE LTD.
14.1.4
MERCK KGAA
14.1.5
MARAVAI LIFESCIENCES
14.1.6
EUROFINS SCIENTIFIC
14.1.7
BIO-RAD LABORATORIES, INC.
14.1.8
QIAGEN
14.1.9
FUJIFILM CORPORATION
14.1.10
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.
14.1.11
HILLGENE BIOPHARMA CO., LTD.
14.1.12
REVVITY
14.1.13
INTERTEK GROUP PLC
14.1.14
SARTORIUS AG
14.1.15
LONZA
14.1.16
WUXI APPTEC
14.2
OTHER PLAYERS
14.2.1
TRANSGEN BIOTECH CO., LTD.
14.2.2
EAGLEBIO
14.2.3
YEASEN
14.2.4
ACROBIOSYSTEMS
14.2.5
CREATIVE BIOGENE
14.2.6
MINERVA BIOLABS GMBH
14.2.7
CREATIVE PROTEOMICS
14.2.8
AVANCE BIOSCIENCES
14.2.9
GENERI BIOTECH
15
APPENDIX
350
15.1
DISCUSSION GUIDE
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
15.4
RELATED REPORTS
15.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
RESIDUAL DNA TESTING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3
RESIDUAL DNA TESTING MARKET: RISK ANALYSIS
TABLE 4
RESIDUAL DNA TESTING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 5
LIST OF FDA-APPROVED BIOSIMILAR PRODUCTS, 2022–2024
TABLE 6
KEY PRODUCT APPROVALS IN GENE THERAPY MARKET, 2022–2024
TABLE 7
AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY KEY PLAYER, 2022–2024 (USD MILLION)
TABLE 8
AVERAGE SELLING PRICE TREND OF RESIDUAL DNA QUANTIFICATION KITS, BY REGION, 2022–2024 (USD MILLION)
TABLE 9
AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2022–2024 (USD MILLION)
TABLE 10
RESIDUAL DNA TESTING MARKET: ROLE IN ECOSYSTEM
TABLE 11
MAJOR INVESTMENT AND FUNDING ACTIVITIES IN RESIDUAL DNA TESTING MARKET, BY KEY PLAYER, 2022−2025
TABLE 12
RESIDUAL DNA TESTING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024
TABLE 13
RESIDUAL DNA TESTING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 14
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
RESIDUAL DNA TESTING MARKET: PORTER’S FIVE FORCES
TABLE 19
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
TABLE 20
KEY BUYING CRITERIA, BY END USER
TABLE 21
LIST OF KEY COMPANIES IMPLEMENTING AI/GEN AI IN RESIDUAL DNA TESTING MARKET
TABLE 22
RESIDUAL DNA TESTING MARKET: IMPORT DATA FOR HS CODE 9027, 2020–2024 (USD THOUSAND)
TABLE 23
RESIDUAL DNA TESTING MARKET: EXPORT DATA FOR HS CODE 9027, 2020–2024 (USD THOUSAND)
TABLE 24
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 25
PRODUCT/COMPONENT-RELATED TARIFFS FOR RESIDUAL DNA TESTING PRODUCTS
TABLE 26
CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
TABLE 27
RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 28
RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 29
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 34
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 36
RESIDUAL DNA TESTING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 37
NORTH AMERICA: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
EUROPE: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
ASIA PACIFIC: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
LATIN AMERICA: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
MIDDLE EAST: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
GCC COUNTRIES: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 44
NORTH AMERICA: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
EUROPE: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
ASIA PACIFIC: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
LATIN AMERICA: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
MIDDLE EAST: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
GCC COUNTRIES: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 58
RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
NORTH AMERICA: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
EUROPE: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
ASIA PACIFIC: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
LATIN AMERICA: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
MIDDLE EAST: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
GCC COUNTRIES: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
NORTH AMERICA: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
EUROPE: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
ASIA PACIFIC: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69
LATIN AMERICA: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
MIDDLE EAST: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 71
GCC COUNTRIES: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 73
NORTH AMERICA: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74
EUROPE: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75
ASIA PACIFIC: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
LATIN AMERICA: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
MIDDLE EAST: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
GCC COUNTRIES: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 80
RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82
EUROPE: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
TABLE 86
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
EUROPE: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 93
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94
RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 95
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
EUROPE: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 100
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 102
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
EUROPE: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 107
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108
RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 109
RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 110
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111
EUROPE: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 115
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116
RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
TABLE 117
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118
EUROPE: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
TABLE 122
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123
RESIDUAL DNA TESTING MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
TABLE 124
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125
EUROPE: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 126
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
TABLE 129
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 131
NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 132
EUROPE: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134
LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135
MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 136
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137
RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 138
RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 139
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 143
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 144
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 145
RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION)
TABLE 146
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION)
TABLE 151
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 152
RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 153
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154
EUROPE: RESIDUAL DNA TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 158
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 159
RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 161
NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162
EUROPE: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 163
ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164
LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 165
MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 166
GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167
RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 168
NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169
EUROPE: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 170
ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171
LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172
MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 173
GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174
RESIDUAL DNA TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 175
RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 176
RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 177
NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179
NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180
NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 181
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 183
NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 184
NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 185
NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 186
NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 187
US: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 188
US: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
US: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 190
US: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 191
US: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 192
US: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 193
US: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 194
CANADA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 195
CANADA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
CANADA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 197
CANADA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 198
CANADA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 199
CANADA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 200
CANADA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 201
EUROPE: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 202
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203
EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204
EUROPE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 205
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
EUROPE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 207
EUROPE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 208
EUROPE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 209
EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 210
EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 211
GERMANY: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 212
GERMANY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
GERMANY: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 214
GERMANY: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 215
GERMANY: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 216
GERMANY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 217
GERMANY: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 218
UK: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 219
UK: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
UK: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 221
UK: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 222
UK: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 223
UK: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 224
UK: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 225
FRANCE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 226
FRANCE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
FRANCE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228
FRANCE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 229
FRANCE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 230
FRANCE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 231
FRANCE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 232
ITALY: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 233
ITALY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
ITALY: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 235
ITALY: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 236
ITALY: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 237
ITALY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 238
ITALY: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 239
SPAIN: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 240
SPAIN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
SPAIN: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 242
SPAIN: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 243
SPAIN: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 244
SPAIN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 245
SPAIN: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 246
REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 247
REST OF EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 249
REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 250
REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 251
REST OF EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER,2023–2030 (USD MILLION)
TABLE 252
REST OF EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 253
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 254
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 255
ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 256
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 257
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 259
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 260
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 261
ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 262
ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 263
CHINA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 264
CHINA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
CHINA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 266
CHINA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 267
CHINA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 268
CHINA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 269
CHINA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 270
JAPAN: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 271
JAPAN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272
JAPAN: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 273
JAPAN: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 274
JAPAN: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 275
JAPAN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 276
JAPAN: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 277
INDIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 278
INDIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
INDIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 280
INDIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 281
INDIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 282
INDIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 283
INDIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 284
SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 285
SOUTH KOREA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 287
SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 288
SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 289
SOUTH KOREA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 290
SOUTH KOREA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 291
AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 292
AUSTRALIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293
AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 294
AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 295
AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 296
AUSTRALIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 297
AUSTRALIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 298
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 299
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 301
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 302
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 303
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 304
REST OF ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 305
LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 306
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 307
LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 308
LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 309
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310
LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 311
LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 312
LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 313
LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 314
LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 315
BRAZIL: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 316
BRAZIL: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317
BRAZIL: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 318
BRAZIL: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 319
BRAZIL: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 320
BRAZIL: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 321
BRAZIL: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 322
MEXICO: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 323
MEXICO: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 324
MEXICO: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 325
MEXICO: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 326
MEXICO: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 327
MEXICO: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 328
MEXICO: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 329
REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 330
REST OF LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 331
REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 332
REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 333
REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 334
REST OF LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 335
REST OF LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 336
MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 337
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 338
MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 339
MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 340
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 341
MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 342
MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 343
MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 344
MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 345
MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 346
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 347
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 348
GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 349
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 350
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 351
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 352
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 353
GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 354
GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 355
GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 356
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 357
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 358
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 359
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 360
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 361
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 362
KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 363
UAE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 364
UAE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 365
UAE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 366
UAE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 367
UAE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 368
UAE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 369
UAE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 370
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 371
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 372
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 373
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 374
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 375
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 376
REST OF GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 377
REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 378
REST OF MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 379
REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 380
REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 381
REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 382
REST OF MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 383
REST OF MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 384
AFRICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
TABLE 385
AFRICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 386
AFRICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 387
AFRICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 388
AFRICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 389
AFRICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 390
AFRICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 391
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RESIDUAL DNA TESTING MARKET
TABLE 392
RESIDUAL DNA TESTING MARKET: DEGREE OF COMPETITION
TABLE 393
RESIDUAL DNA TESTING MARKET: REGION FOOTPRINT
TABLE 394
RESIDUAL DNA TESTING MARKET: OFFERING FOOTPRINT
TABLE 395
RESIDUAL DNA TESTING MARKET: TECHNOLOGY FOOTPRINT
TABLE 396
RESIDUAL DNA TESTING MARKET: TEST TYPE FOOTPRINT
TABLE 397
RESIDUAL DNA TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 398
RESIDUAL DNA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
TABLE 399
RESIDUAL DNA TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
TABLE 400
RESIDUAL DNA TESTING MARKET: DEALS, JANUARY 2021–MAY 2025
TABLE 401
RESIDUAL DNA TESTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2025
TABLE 402
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 403
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 404
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–MAY 2025
TABLE 405
THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
TABLE 406
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 407
CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 408
CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2022–MAY 2025
TABLE 409
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 410
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 411
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 412
MERCK KGAA: COMPANY OVERVIEW
TABLE 413
MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 414
MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 415
MERCK KGAA: EXPANSIONS, JANUARY 2022–MAY 2025
TABLE 416
MARAVAI LIFESCIENCES: COMPANY OVERVIEW
TABLE 417
MARAVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED
TABLE 418
MARAVAI LIFESCIENCES: DEALS, JANUARY 2022–MAY 2025
TABLE 419
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 420
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 421
EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–MAY 2025
TABLE 422
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 423
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 424
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–MAY 2025
TABLE 425
QIAGEN: COMPANY OVERVIEW
TABLE 426
QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 427
QIAGEN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 428
FUJIFILM CORPORATION: COMPANY OVERVIEW
TABLE 429
FUJIFILM CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 430
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: COMPANY OVERVIEW
TABLE 431
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: PRODUCTS/SERVICES OFFERED
TABLE 432
HILLGENE BIOPHARMA CO., LTD.: COMPANY OVERVIEW
TABLE 433
HILLGENE BIOPHARMA CO., LTD.: PRODUCTS/SERVICES OFFERED
TABLE 434
REVVITY: COMPANY OVERVIEW
TABLE 435
REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 436
REVVITY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
TABLE 437
INTERTEK GROUP PLC: COMPANY OVERVIEW
TABLE 438
INTERTEK GROUP PLC: PRODUCTS/SERVICES OFFERED
TABLE 439
SARTORIUS AG: COMPANY OVERVIEW
TABLE 440
SARTORIUS AG: PRODUCTS/SERVICES OFFERED
TABLE 441
LONZA: COMPANY OVERVIEW
TABLE 442
LONZA: PRODUCTS/SERVICES OFFERED
TABLE 443
WUXI APPTEC: COMPANY OVERVIEW
TABLE 444
WUXI APPTEC: PRODUCTS/SERVICES OFFERED
TABLE 445
TRANSGEN BIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 446
EAGLEBIO: COMPANY OVERVIEW
TABLE 447
YEASEN: COMPANY OVERVIEW
TABLE 448
ACROBIOSYSTEMS: COMPANY OVERVIEW
TABLE 449
CREATIVE BIOGENE: COMPANY OVERVIEW
TABLE 450
MINERVA BIOLABS GMBH: COMPANY OVERVIEW
TABLE 451
CREATIVE PROTEOMICS: COMPANY OVERVIEW
TABLE 452
AVANCE BIOSCIENCES: COMPANY OVERVIEW
TABLE 453
GENERI BIOTECH: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
RESIDUAL DNA TESTING MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
RESIDUAL DNA TESTING MARKET: YEARS CONSIDERED
FIGURE 3
RESIDUAL DNA TESTING MARKET: RESEARCH DESIGN
FIGURE 4
RESIDUAL DNA TESTING MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
FIGURE 5
RESIDUAL DNA TESTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 6
RESIDUAL DNA TESTING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2024)
FIGURE 7
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2024)
FIGURE 8
RESIDUAL DNA TESTING MARKET: INSIGHTS FROM PRIMARIES
FIGURE 9
RESIDUAL DNA TESTING MARKET: TOP-DOWN APPROACH
FIGURE 10
RESIDUAL DNA TESTING MARKET: CAGR PROJECTIONS
FIGURE 11
RESIDUAL DNA TESTING MARKET: DATA TRIANGULATION
FIGURE 12
RESIDUAL DNA TESTING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
FIGURE 13
RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 14
RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 15
RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 16
RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 17
RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18
REGIONAL ANALYSIS OF RESIDUAL DNA TESTING MARKET
FIGURE 19
INCREASE IN NUMBER OF BIOLOGICS AND BIOSIMILAR APPROVALS TO DRIVE MARKET
FIGURE 20
US AND FINAL PRODUCT RELEASE TESTING ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024
FIGURE 21
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES COMMANDED LARGEST MARKET SHARE IN 2024
FIGURE 22
CHINA TO WITNESS HIGHEST CAGR DURING STUDY PERIOD
FIGURE 23
RESIDUAL DNA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24
GLOBAL TOTAL PHARMACEUTICAL R&D SPEND, 2016–2030
FIGURE 25
RESIDUAL DNA TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 26
AVERAGE SELLING PRICE OF DNA QUANTIFICATION KITS, BY KEY PLAYER, 2024 (USD)
FIGURE 27
AVERAGE SELLING PRICE TREND OF PCR SYSTEMS, BY KEY PLAYER, 2022–2024 (USD)
FIGURE 28
AVERAGE SELLING PRICE OF RESIDUAL DNA TESTING PRODUCTS, BY REGION, 2024 (USD)
FIGURE 29
RESIDUAL DNA TESTING MARKET: VALUE CHAIN ANALYSIS
FIGURE 30
RESIDUAL DNA TESTING MARKET: ECOSYSTEM ANALYSIS
FIGURE 31
FUNDING AND NUMBER OF DEALS IN RESIDUAL DNA TESTING MARKET, 2021–2024
FIGURE 32
TOP APPLICANTS OF RESIDUAL DNA TESTING PATENTS, 2014–2024
FIGURE 33
RESIDUAL DNA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 34
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 35
KEY BUYING CRITERIA, BY END USER
FIGURE 36
RESIDUAL DNA TESTING MARKET: KEY AI USE CASES
FIGURE 37
NORTH AMERICA: RESIDUAL DNA TESTING MARKET SNAPSHOT
FIGURE 38
ASIA PACIFIC: RESIDUAL DNA TESTING MARKET SNAPSHOT
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN RESIDUAL DNA TESTING MARKET, 2020–2024 (USD MILLION)
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS IN RESIDUAL DNA TESTING MARKET (2024)
FIGURE 41
RESIDUAL DNA TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 42
RESIDUAL DNA TESTING MARKET: COMPANY FOOTPRINT
FIGURE 43
RESIDUAL DNA TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 44
WEV/EBITDA OF KEY VENDORS
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 46
RESIDUAL DNA TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 48
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
FIGURE 49
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 50
MERCK KGAA: COMPANY SNAPSHOT
FIGURE 51
MARAVAI LIFESCIENCES: COMPANY SNAPSHOT
FIGURE 52
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 53
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 54
QIAGEN: COMPANY SNAPSHOT
FIGURE 55
FUJIFILM CORPORATION: COMPANY SNAPSHOT
FIGURE 56
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: COMPANY SNAPSHOT
FIGURE 57
HILLGENE BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
FIGURE 58
REVVITY: COMPANY SNAPSHOT
FIGURE 59
INTERTEK GROUP PLC: COMPANY SNAPSHOT
FIGURE 60
SARTORIUS AG: COMPANY SNAPSHOT
FIGURE 61
LONZA: COMPANY SNAPSHOT
FIGURE 62
WUXI APPTEC: COMPANY SNAPSHOT
Methodology
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global residual DNA testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), United States Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the residual DNA testing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Residual DNA testing involves the detection and quantification of DNA impurities from host cells present in biopharmaceutical products. This testing is a critical component in the quality assurance of biologics, as it assesses the levels of residual DNA that may remain in the final product, bulk intermediates, or raw materials post-purification. The market for residual DNA testing encompasses a diverse array of analytical tools and services tailored to meet stringent regulatory requirements. Compliance with guidelines established by the FDA, WHO, and GxP standards necessitates a thorough evaluation of host cell DNA to mitigate risks and ensure safety and efficacy in biologics. This regulatory landscape makes residual DNA testing a vital focus area in the development and manufacturing of biologic products, emphasizing the need for precision and reliability in these assessments.
Stakeholders
- Pharmaceutical & biotechnology companies
- Academic researchers and government research organizations
- Private research institutes
- Custom residual DNA testing service providers
- Contract development & manufacturing organizations (CDMOs)
- Life Science Companies
- Contract research organizations (CROs)
- Market research & consulting firms
- Venture capitalists
Report Objectives
- To define, describe, and forecast the global residual DNA testing market by offering, technology, test type, application, end user (product), end user (service), and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall residual DNA testing market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the residual DNA testing market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the residual DNA testing market.
Key Questions Addressed by the Report
Who are the key players in the residual DNA testing market?
Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Maravai LifeSciences (US), FUJIFILM Corporation (Japan), SGS Société Générale de Surveillance SA. (Switzerland), Jiangsu Hillgene Biopharma Co., Ltd (China), Revvity (US), Intertek Group plc (UK), WuXi AppTec (China), Sartorius AG (Germany), and Lonza (Switzerland).
Which product segment dominates the residual DNA testing market?
Consumables are expected to dominate the market in the product segment, driven by the recurring nature of demand.
Which application segment of the residual DNA testing market is expected to witness the highest growth?
The cell & gene therapies applications segment is expected to register the highest growth during the forecast period, mainly due to regulatory requirements and the complexity of viral vector-based production systems.
Which end user segment of the residual DNA testing market is expected to witness the highest growth?
Pharmaceutical & biotechnology companies accounted for the largest market share and the highest growth by end users in 2024 due to the stringent regulatory requirements for product safety and quality.
What is the market size for the residual DNA market?
The global residual DNA testing market is projected to reach USD 0.37 billion by 2030 from USD 0.28 billion in 2025, at a CAGR of 6.0% during the forecast period.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Residual DNA Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Residual DNA Testing Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Residual DNA Testing Market